Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)

BACKGROUND: Selective cyclooxygenase-2 inhibitors and conventional non-selective non-steroidal anti-inflammatory drugs (nsNSAIDs) have been associated with adverse cardiovascular (CV) effects. We compared the CV safety of switching to celecoxib vs. continuing nsNSAID therapy in a European setting. M...

Descripción completa

Detalles Bibliográficos
Autores principales: MacDonald, Thomas M., Hawkey, Chris J., Ford, Ian, McMurray, John J.V., Scheiman, James M., Hallas, Jesper, Findlay, Evelyn, Grobbee, Diederick E., Hobbs, F.D. Richard, Ralston, Stuart H., Reid, David M., Walters, Matthew R., Webster, John, Ruschitzka, Frank, Ritchie, Lewis D., Perez-Gutthann, Susana, Connolly, Eugene, Greenlaw, Nicola, Wilson, Adam, Wei, Li, Mackenzie, Isla S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837371/
https://www.ncbi.nlm.nih.gov/pubmed/27705888
http://dx.doi.org/10.1093/eurheartj/ehw387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837371/
https://www.ncbi.nlm.nih.gov/pubmed/27705888
http://dx.doi.org/10.1093/eurheartj/ehw387

Ejemplares similares